Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia [17]

New England Journal of Medicine

Volumn 354, Issue 24, 2006, Pages 2623-2624

  Assouline, Sarit ^a   Laneuville, Pierre ^b   Gambacorti Passerini, Carlo ^c  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DASATINIB; IMATINIB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PREDNISONE; PROTEIN TYROSINE KINASE;

ADULT; AGED; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; DOSE RESPONSE; DRUG TOLERABILITY; ENZYME INHIBITION; ERYTHEMA; FEMALE; FEVER; GENE MUTATION; HUMAN; HUMAN TISSUE; LETTER; METAPHASE; NEUTROPHIL CHEMOTAXIS; PANNICULITIS; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; SKIN BIOPSY; SKIN NODULE; STEROID THERAPY; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC-PHASE; MIDDLE AGED; PANNICULITIS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRIMIDINES; THIAZOLES;

EID: 33745059989     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc053425     Document Type: Letter

References (1)

1. Gambacorti-Passerini C, Gunby RH, Piazza R, Galietta A, Rostagno R, Scapozza L. Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukemias. Lancet Oncol 2003;4:75-85.